364 related articles for article (PubMed ID: 25292031)
1. Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma.
Tang JF; Yu ZH; Liu T; Lin ZY; Wang YH; Yang LW; He HJ; Cao J; Huang HL; Liu G
Asian Pac J Cancer Prev; 2014; 15(18):7575-81. PubMed ID: 25292031
[TBL] [Abstract][Full Text] [Related]
2. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
[TBL] [Abstract][Full Text] [Related]
3. miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma.
Jiang L; Zhang Y; Li B; Kang M; Yang Z; Lin C; Hu K; Wei Z; Xu M; Mi J; Wang R; Wu F
Cancer Sci; 2021 Jun; 112(6):2393-2404. PubMed ID: 33728743
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W
Gene; 2020 Feb; 727():144243. PubMed ID: 31743768
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma.
Zheng XH; Lu LX; Cui C; Chen MY; Li XZ; Jia WH
Oncotarget; 2016 Jan; 7(4):4972-80. PubMed ID: 26701721
[TBL] [Abstract][Full Text] [Related]
6. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
[TBL] [Abstract][Full Text] [Related]
7. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
8. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
9. Plasma microRNA profiling in nasopharyngeal carcinoma patients reveals miR-548q and miR-483-5p as potential biomarkers.
Zheng XH; Cui C; Ruan HL; Xue WQ; Zhang SD; Hu YZ; Zhou XX; Jia WH
Chin J Cancer; 2014 Jul; 33(7):330-8. PubMed ID: 24874644
[TBL] [Abstract][Full Text] [Related]
10. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
[TBL] [Abstract][Full Text] [Related]
11. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
[TBL] [Abstract][Full Text] [Related]
12. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
13. Circulating miR-31-5p may be a potential diagnostic biomarker in nasopharyngeal carcinoma.
Yi SJ; Liu P; Chen BL; Ou-Yang L; Xiong WM; Su JP
Neoplasma; 2019 Sep; 66(5):825-829. PubMed ID: 31129965
[TBL] [Abstract][Full Text] [Related]
14. H19/miR-675-5p Targeting SFN Enhances the Invasion and Metastasis of Nasalpharyngeal Cancer Cells.
Zhang T; Lei F; Jiang T; Xie L; Huang P; Li P; Huang Y; Tang X; Gong J; Lin Y; Cheng A; Huang W
Curr Mol Pharmacol; 2019; 12(4):324-333. PubMed ID: 31677258
[TBL] [Abstract][Full Text] [Related]
15. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma.
Wang J; Zhang H; Zhou X; Wang T; Zhang J; Zhu W; Zhu H; Cheng W
Cancer Biomark; 2018; 23(2):193-203. PubMed ID: 30198863
[TBL] [Abstract][Full Text] [Related]
16. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-129-5p suppresses nasopharyngeal carcinoma lymphangiogenesis and lymph node metastasis by targeting ZIC2.
Yu D; Han GH; Zhao X; Liu X; Xue K; Wang D; Xu CB
Cell Oncol (Dordr); 2020 Apr; 43(2):249-261. PubMed ID: 31884576
[TBL] [Abstract][Full Text] [Related]
18. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
19. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
Liu M; Zhu K; Qian X; Li W
Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
[TBL] [Abstract][Full Text] [Related]
20. Identification of non-invasive biomarkers for predicting the radiosensitivity of nasopharyngeal carcinoma from serum microRNAs.
Li K; Zhu X; Li L; Ning R; Liang Z; Zeng F; Su F; Huang S; Yang X; Qu S
Sci Rep; 2020 Mar; 10(1):5161. PubMed ID: 32198434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
